愛博醫療(688050):就股價異常波動進行説明 不存在其他應披露而未披露的重大信息
格隆匯5月13日丨愛博醫療(688050)發佈公吿,公司股票交易連續3個交易日內(2021年5月10日、2021年5月11日、2021年5月12日)收盤價格漲幅偏離值累計達到30%以上,根據《上海證券交易所交易規則》、《上海證券交易所科創板股票交易特別規定》、《上海證券交易所科創板股票異
常交易實時監控細則
(試行)》的有關規定,屬於股票交易異常波動的情形。
經公司自查併發函問詢控股股東、實際控制人,截至2021年5月12日,公司
及控股股東、實際控制人不存在影響公司股票交易異常波動的重大事項,亦不存
在其他應披露而未披露的重大信息,包括但不限於重大資產重組、股份發行、上
市公司收購、債務重組、業務重組、資產剝離和資產注入等重大事項。公司未發
現前期披露的信息存在需要更正、補充之處。
截至2021年5月12日,公司收盤價為266.78元/股,根據中證指數有限公司發布的數據,公司最新滾動市盈率為242.02倍,公司所處的專用設備製造業最近一
個月平均滾動市盈率為36.34倍,公司市盈率高於行業市盈率水平。敬請投資者
理性投資,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.